These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 30870834)
1. Decreased miR-218-5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer. Peng P; Chen T; Wang Q; Zhang Y; Zheng F; Huang S; Tang Y; Yang C; Ding W; Ren D; Huang Z; Guo Y Oncol Res Treat; 2019; 42(4):165-185. PubMed ID: 30870834 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer. Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848 [TBL] [Abstract][Full Text] [Related]
3. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling. Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537 [No Abstract] [Full Text] [Related]
4. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway. Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling. Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600 [TBL] [Abstract][Full Text] [Related]
6. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells. Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561 [TBL] [Abstract][Full Text] [Related]
7. miR-204-5p Represses Bone Metastasis via Inactivating NF-κB Signaling in Prostate Cancer. Wa Q; Huang S; Pan J; Tang Y; He S; Fu X; Peng X; Chen X; Yang C; Ren D; Huang Y; Liao Z; Huang S; Zou C Mol Ther Nucleic Acids; 2019 Dec; 18():567-579. PubMed ID: 31678733 [TBL] [Abstract][Full Text] [Related]
8. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition. Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-β signaling. Huang S; Wa Q; Pan J; Peng X; Ren D; Li Q; Dai Y; Yang Q; Huang Y; Zhang X; Zhou W; Yuan D; Cao J; Li Y; He P; Tang Y Cell Death Dis; 2018 Jul; 9(7):779. PubMed ID: 30006541 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2. Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091 [TBL] [Abstract][Full Text] [Related]
11. miR-582-3p and miR-582-5p Suppress Prostate Cancer Metastasis to Bone by Repressing TGF-β Signaling. Huang S; Zou C; Tang Y; Wa Q; Peng X; Chen X; Yang C; Ren D; Huang Y; Liao Z; Huang S; Zou X; Pan J Mol Ther Nucleic Acids; 2019 Jun; 16():91-104. PubMed ID: 30852380 [TBL] [Abstract][Full Text] [Related]
12. Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model. Lin Y; Chen F; Shen L; Tang X; Du C; Sun Z; Ding H; Chen J; Shen B J Transl Med; 2018 May; 16(1):134. PubMed ID: 29784056 [TBL] [Abstract][Full Text] [Related]
13. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887 [TBL] [Abstract][Full Text] [Related]
14. MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway. Yang Q; Lang C; Wu Z; Dai Y; He S; Guo W; Huang S; Du H; Ren D; Peng X J Exp Clin Cancer Res; 2019 Sep; 38(1):391. PubMed ID: 31488180 [TBL] [Abstract][Full Text] [Related]
15. Discovery of extracellular vesicles derived miR-181a-5p in patient's serum as an indicator for bone-metastatic prostate cancer. Wang Y; Fang YX; Dong B; Du X; Wang J; Wang X; Gao WQ; Xue W Theranostics; 2021; 11(2):878-892. PubMed ID: 33391510 [No Abstract] [Full Text] [Related]
16. Identifying the key genes and microRNAs in prostate cancer bone metastasis by bioinformatics analysis. Zhu Z; Wen Y; Xuan C; Chen Q; Xiang Q; Wang J; Liu Y; Luo L; Zhao S; Deng Y; Zhao Z FEBS Open Bio; 2020 Apr; 10(4):674-688. PubMed ID: 32027093 [TBL] [Abstract][Full Text] [Related]
17. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer. Tinay I; Tan M; Gui B; Werner L; Kibel AS; Jia L Prostate; 2018 Sep; 78(12):927-937. PubMed ID: 29748958 [TBL] [Abstract][Full Text] [Related]
18. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo. Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer. Liu J; Li J; Ma Y; Xu C; Wang Y; He Y Bioengineered; 2021 Dec; 12(1):3240-3251. PubMed ID: 34238129 [TBL] [Abstract][Full Text] [Related]
20. Ectopic Expression of miR-532-3p Suppresses Bone Metastasis of Prostate Cancer Cells via Inactivating NF-κB Signaling. Wa Q; Zou C; Lin Z; Huang S; Peng X; Yang C; Ren D; Xu D; Guo Y; Liao Z; Wang B; Hu H; Huang S; He P Mol Ther Oncolytics; 2020 Jun; 17():267-277. PubMed ID: 32368615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]